Approval for Genentech's vismodegib marked the first approval for a Hedgehog inhibitor, but questions remain for the class's broader role in other cancers.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Berberine, a natural compound, suppresses Hedgehog signaling pathway activity and cancer growth
BMC Cancer Open Access 22 August 2015
-
GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating Gli
Molecular Cancer Open Access 07 January 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Guha, M. Hedgehog inhibitor gets landmark skin cancer approval, but questions remain for wider potential. Nat Rev Drug Discov 11, 257–258 (2012). https://doi.org/10.1038/nrd3714
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3714
This article is cited by
-
Protein arginine methyltransferase 1 interacts with Gli1 and regulates its transcriptional activity
Tumor Biology (2016)
-
Berberine, a natural compound, suppresses Hedgehog signaling pathway activity and cancer growth
BMC Cancer (2015)
-
AT-101 inhibits hedgehog pathway activity and cancer growth
Cancer Chemotherapy and Pharmacology (2015)
-
GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating Gli
Molecular Cancer (2014)
-
Expression of Hedgehog ligand and signal transduction components in mutually distinct isocitrate dehydrogenase mutant glioma cells supports a role for paracrine signaling
Journal of Neuro-Oncology (2014)